RELYVRIO

Serial Number 90544439
Registration 6975321
700

Registration Progress

Application Filed
Feb 24, 2021
Under Examination
Jun 14, 2022
Approved for Publication
Oct 26, 2021
Published for Opposition
Oct 26, 2021
Registered
Feb 7, 2023

Trademark Image

RELYVRIO

Basic Information

Serial Number
90544439
Registration Number
6975321
Filing Date
February 24, 2021
Registration Date
February 7, 2023
Published for Opposition
October 26, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 7, 2023
Registration
Registered
Classes
005

Rights Holder

Amylyx Pharmaceuticals, Inc.

03
Address
43 Thorndike Street
Cambridge, MA 02141

Ownership History

Amylyx Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Amylyx Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Amylyx Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Cynthia Johnson Walden

USPTO Deadlines

Next Deadline
1135 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230207)
Due Date
February 07, 2029
Grace Period Ends
August 07, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Feb 7, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 7, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 5, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 5, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 30, 2022 IUAF S USE AMENDMENT FILED Loading...
Jan 5, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 14, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 4, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 14, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 5, 2022 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Oct 26, 2021 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Oct 26, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 26, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 6, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 25, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 27, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases
First Use Anywhere: Oct 17, 2022
First Use in Commerce: Oct 17, 2022

Classification

International Classes
005